HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beyond the brain: do peripheral mechanisms develop impaired awareness of hypoglycemia?

Abstract
The mechanisms responsible for the development of the impaired awareness of hypoglycemia often seen in insulin-treated patients with diabetes remain uncertain, but cerebral adaptations to recurrent hypoglycemia are frequently hypothesized. In this issue of the JCI, Ma et al. demonstrate that neuropeptide Y (NPY) secretion from adrenal chromaffin cells persists during exposure to recurrent hypoglycemia and activation of the sympathetic nerves at the same time that epinephrine secretion is reduced. This results in the inhibition of tyrosine hydroxylase, the rate-limiting enzyme for catecholamine synthesis. These observations suggest that a peripheral mechanism downstream from the brain contributes to the development of impaired awareness of hypoglycemia.
AuthorsElizabeth R Seaquist
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 128 Issue 9 Pg. 3739-3741 (08 31 2018) ISSN: 1558-8238 [Electronic] United States
PMID30080180 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Comment)
Chemical References
  • Insulin
  • Neuropeptide Y
  • Tyrosine 3-Monooxygenase
Topics
  • Brain
  • Humans
  • Hypoglycemia
  • Insulin
  • Neuropeptide Y
  • Tyrosine 3-Monooxygenase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: